Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Debt Repayments (2018 - 2019)

Organogenesis Holdings has reported Long-Term Debt Repayments over the past 2 years, most recently at $31.5 million for Q4 2019.

  • Quarterly results put Long-Term Debt Repayments at $31.5 million for Q4 2019, changed N/A from a year ago — trailing twelve months through Dec 2021 was $31.5 million (changed 0.0% YoY), and the annual figure for FY2021 was -$60.0 million, down 700.0%.
  • Long-Term Debt Repayments for Q4 2019 was $31.5 million at Organogenesis Holdings, up from $17.6 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for ORGO hit a ceiling of $31.5 million in Q4 2019 and a floor of $10000.0 in Q1 2018.